TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16389695

Group type: EXPERIMENTAL
Intervention: Female model (young or old)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Male model (young or old)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Model gender influence
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Model age influence
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Model gender influence on exercise form
Number of subjects: 40
Study: 12049567

Group type: EXPERIMENTAL
Intervention: 500 rad (5 Gy) irradiation at 1 minute post-treatment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 500 rad (5 Gy) irradiation at 2 minutes post-treatment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 500 rad (5 Gy) irradiation at 3 minutes post-treatment
Number of subjects: 27
Study: 10607256

Group type: EXPERIMENTAL
Intervention: Thymosin alpha1 (Talpha1) 1.6 mg, twice weekly for 6 months
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo, twice weekly for 6 months
Number of subjects: 97
Study: 8578549

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (ASA)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Haemodialysis
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 34
Study: 2338114

Group type: EXPERIMENTAL
Intervention: cimetidine 600 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study: 7002356

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 31151446

Group type: EXPERIMENTAL
Intervention: Fast-track assessment in medical examination chairs
Number of subjects: 3632
Study: 27813347

Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) rehabilitation protocol
Number of subjects: 162

Group type: COMPARATOR
Intervention: Low-Intensity (LI) rehabilitation protocol
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both HI and LI interventions
Number of subjects: 162
Study: 27183124

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Continuous Aerobic Exercise (CONT)
Number of subjects: 14
Study: 23895200

Group type: EXPERIMENTAL
Intervention: Self-determination theory (SDT) constructs including family routines, confidence, and importance
Number of subjects: 168
Study: 21822627

Group type: EXPERIMENTAL
Intervention: Community mobilization strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based mobile voluntary counseling and testing and post-test support services
Number of subjects: 0
Study: 19828937

Group type: EXPERIMENTAL
Intervention: Homoeopathic treatment
Number of subjects: 135

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 135
Study: 17551297

Group type: EXPERIMENTAL
Intervention: Pd-103
Number of subjects: 263

Group type: COMPARATOR
Intervention: I-125
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Both isotopes
Number of subjects: 263
Study: 11964644

Group type: EXPERIMENTAL
Intervention: Collared HD-II femoral component
Number of subjects: 84

Group type: COMPARATOR
Intervention: Collarless HD-II femoral component
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 9655654

Group type: EXPERIMENTAL
Intervention: Transdermal 17‐beta‐oestradiol (100 microg per 24 h)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 7865266

Group type: EXPERIMENTAL
Intervention: PDP (foam pressure dispersing pads) worn throughout hospitalization
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no PDP)
Number of subjects: 54
Study: 2644049

Group type: COMPARATOR
Intervention: 40 per cent O2 venturi masks
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nasal catheters
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nasal catheters and 40 per cent O2 masks
Number of subjects: 161
Study: 29497859

Group type: EXPERIMENTAL
Intervention: Monopolar transurethral resection (mTURB)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection (bTURB)
Number of subjects: 52
Study: 27600829

Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg + MTX
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg + MTX
Number of subjects: 1197

Group type: COMPARATOR
Intervention: Placebo + MTX
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Sarilumab (both doses)
Number of subjects: 1197
Study: 25661064

Group type: EXPERIMENTAL
Intervention: BoNT‐A
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BITT + BoNT‐A
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BITT
Number of subjects: 35

Group type: COMPARATOR
Intervention: BITT‐only
Number of subjects: 35

Group type: COMPARATOR
Intervention: BoNT‐A + BITT
Number of subjects: 35
Study: 22775481

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Continuous combined oral E(2) 2 mg/NETA 1 mg daily
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 21915249

Group type: EXPERIMENTAL
Intervention: Carraguard vaginal gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylcellulose placebo gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: No product
Number of subjects: 60
Study: 18353393

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg 3 times a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17166821

Group type: EXPERIMENTAL
Intervention: Lateral taping
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medial taping
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neutral taping
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-tape
Number of subjects: 24
Study: 14977479

Group type: EXPERIMENTAL
Intervention: High-dose immunosuppression followed by autologous hematopoietic stem cell transplantation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mitoxantrone (best available therapy)
Number of subjects: 200
Study: 11566828

Group type: EXPERIMENTAL
Intervention: Voice therapy for six weeks
Number of subjects: 204

Group type: COMPARATOR
Intervention: Voice therapy
Number of subjects: 204
Study: 10933407

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-PUFA diet (HP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-MUFA diet (HM)
Number of subjects: 45
Study: 7868667

Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination (IUI) after ovarian stimulation with HMG and HCG
Number of subjects: 76

Group type: COMPARATOR
Intervention: Timed intercourse after ovarian stimulation with HMG and HCG
Number of subjects: 76
Study: 3063046

Group type: EXPERIMENTAL
Intervention: Group I: Anesthesia induced with diazepam (94 micrograms x kg‐1), thiopentone (3 mg x kg‐1), and fentanyl (3 micrograms x kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group II: Anesthesia induced with fentanyl (30 micrograms x kg‐1)
Number of subjects: 30
Study: 30925267

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine infusion
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo infusion (normal saline)
Number of subjects: 71
Study: 29122812

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/d)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Metoprolol succinate (100 mg/d)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vitamin C coinfusion
Number of subjects: 44
Study: 25300649

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D co-supplementation
Number of subjects: 104
Study: 23388543

Group type: EXPERIMENTAL
Intervention: Azathioprine 2.0 to 2.5 mg/kg per day
Number of subjects: 23

Group type: COMPARATOR
Intervention: Mesalamine 4 g/d
Number of subjects: 23
Study: 21852221

Group type: EXPERIMENTAL
Intervention: RT(compFB)
Number of subjects: 31

Group type: COMPARATOR
Intervention: RT(compNoFB)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: RT(clin)
Number of subjects: 31
Study: 19083482

Group type: EXPERIMENTAL
Intervention: L-ornithine (2000 mg/d for 7 days and 6000 mg/d for 1 day as L-ornithine hydrochloride)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: L-ornithine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16868238

Group type: EXPERIMENTAL
Intervention: INFOFEED+NE
Number of subjects: 1337

Group type: COMPARATOR
Intervention: INFOFEED
Number of subjects: 1337
Study: 12757160

Group type: EXPERIMENTAL
Intervention: Erythromycin 200 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Morphine 8 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 9
Study: 11144396

Group type: EXPERIMENTAL
Intervention: Cefdinir 14 mg/kg/day divided twice a day for 5 days
Number of subjects: 373

Group type: COMPARATOR
Intervention: Cefprozil 30 mg/kg/day divided twice a day for 10 days
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 373

Group type: COMPARATOR
Intervention: Cefprozil
Number of subjects: 373
Study: 9058327

Group type: EXPERIMENTAL
Intervention: 10% doxycycline hyclate (DH)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 5% sanguinarium chloride (SC)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Vehicle control (VC)
Number of subjects: 180
Study: 30096092

Group type: EXPERIMENTAL
Intervention: Rifaximin (1100 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25758623

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 140
Study: 23659492

Group type: EXPERIMENTAL
Intervention: Partner + implementation intentions
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Partner-only
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Implementation intentions
Number of subjects: 427

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 427
Study: 21943810

Group type: EXPERIMENTAL
Intervention: Experimental RMTC (E-RMTC)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control parole supervision and case management (PSCM)
Number of subjects: 127
Study: 20082922

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simvastatin 20 to 40 mg daily
Number of subjects: 0
Study: 16170525

Group type: EXPERIMENTAL
Intervention: Preoperative pain training by nursing staff
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no preoperative pain training)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both groups (increased levels of neuroticism)
Number of subjects: 93
Study: 15278040

Group type: EXPERIMENTAL
Intervention: Mechanical methods of hemostasis plus epinephrine injection
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epinephrine injection alone
Number of subjects: 90
Study: 11804427

Group type: EXPERIMENTAL
Intervention: Nafarelin (200 microg by nasal route twice a day)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Leuprolide (0.5 mg by subcutaneous route once a day)
Number of subjects: 238
Study: 9164885

Group type: EXPERIMENTAL
Intervention: Ventricular rate control and anticoagulation
Number of subjects: 5300

Group type: COMPARATOR
Intervention: Rhythm control and anticoagulation
Number of subjects: 5300

Group type: EXPERIMENTAL
Intervention: Both interventions (ventricular rate control and rhythm control)
Number of subjects: 5300
Study: 8203940

Group type: EXPERIMENTAL
Intervention: Movement therapy
Number of subjects: 12
Study: 2953500

Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms X kg‐1 (n = 16)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sufentanil 15 micrograms X kg‐1 (n = 17)
Number of subjects: 33
Study: 31769226

Group type: EXPERIMENTAL
Intervention: Smartphone application (app) intervention for 4 months
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no app intervention)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: App usage in weeks 1-4: 94%
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Mean app use time per participant: Cancer Information: 6.9 minutes (SD: 18.9), Appointment Schedule: 5.1 minutes (SD: 9.6), Cancer Services: 1.5 minutes (SD: 6.8), Hospital Navigation: 1.4 minutes (SD: 2.8)
Number of subjects: 82
Study: 29761242

Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 66
Study: 28543914

Group type: EXPERIMENTAL
Intervention: Intervention premises audited by Environmental Health Practitioners with varying doses (informal advice, written advice, follow-up visits)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control premises received usual practice
Number of subjects: 600
Study: 26051483

Group type: EXPERIMENTAL
Intervention: Post-operative bracing for three weeks after ACL reconstruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: No post-operative bracing for three weeks after ACL reconstruction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Post-operative bracing
Number of subjects: 60
Study: 24175958

Group type: EXPERIMENTAL
Intervention: Low glycemic index dietary intervention
Number of subjects: 800
Study: 21940954

Group type: EXPERIMENTAL
Intervention: Carotid intima-media thickness
Number of subjects: 18155

Group type: EXPERIMENTAL
Intervention: Carotid plaque presence
Number of subjects: 18155

Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy
Number of subjects: 18155
Study: 18245177

Group type: EXPERIMENTAL
Intervention: D-cycloserine, 100 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 16719601

Group type: EXPERIMENTAL
Intervention: Tailored nutrition education messages
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nontailored nutrition education messages
Number of subjects: 24
Study: 15231442

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Untreated MDD
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Successful treatment with antidepressants
Number of subjects: 38
Study: 11196404

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum used regularly for 2 or 3 school years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Occlusal sealants applied
Number of subjects: 0
Study: 9052367

Group type: EXPERIMENTAL
Intervention: Echocardiography in elite orienteers
Number of subjects: 143

Group type: COMPARATOR
Intervention: Echocardiography in controls
Number of subjects: 143
Study: 8375791

Group type: EXPERIMENTAL
Intervention: Crataegus special extract WS 1442
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3098923

Group type: EXPERIMENTAL
Intervention: Progabide
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 31451487

Group type: EXPERIMENTAL
Intervention: 177Lu-labeled PSMA-617
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSMA-targeted imaging
Number of subjects: 0
Study: 28485095

Group type: EXPERIMENTAL
Intervention: myo-inositol
Number of subjects: 60

Group type: COMPARATOR
Intervention: metformin
Number of subjects: 60
Study: 25210833

Group type: COMPARATOR
Intervention: Conventional open plating (COP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (MIPO)
Number of subjects: 68
Study: 22932947

Group type: EXPERIMENTAL
Intervention: Soft gel capsule L-T4 taken with water (proper habit, PH)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Soft gel capsule L-T4 taken with coffee ≤ 5 min later (improper habit, IH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Soft gel capsule L-T4 taken with water (PH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Soft gel capsule L-T4 taken with coffee (IH)
Number of subjects: 8
Study: 20798662

Group type: COMPARATOR
Intervention: Withdrawal of exercise for 1 week in highly active men (Study 1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 30 min of daily walking at 60% VO(2max) for 1 week in sedentary men (Study 2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baseline CRP in highly active men (Study 1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baseline CRP in sedentary men (Study 2)
Number of subjects: 18
Study: 19103494

Group type: EXPERIMENTAL
Intervention: Isoflurane (n=27)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sevoflurane (n=27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 54

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 54
Study: 17011155

Group type: EXPERIMENTAL
Intervention: Written information plus illustrations
Number of subjects: 318

Group type: COMPARATOR
Intervention: Written information only
Number of subjects: 318
Study: 15292698

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (BR1, SonoVue, Bracco)
Number of subjects: 62
Study: 11414003

Group type: EXPERIMENTAL
Intervention: Focused attention induced by peripheral cues of varying sizes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral precue indicating target position
Number of subjects: 0

Group type: COMPARATOR
Intervention: No specific control intervention mentioned
Number of subjects: 0
Study: 9226291

Group type: EXPERIMENTAL
Intervention: Compression rate of 5:1
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Compression rate of 6:1
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Compression rate of 11:1
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Compression rate of 43:1
Number of subjects: 1440
Study: 8501502

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 600 mg/m2 + Carboplatin 300 mg/m2
Number of subjects: 224

Group type: COMPARATOR
Intervention: Single-agent Carboplatin
Number of subjects: 224
Study: 3114783

Group type: EXPERIMENTAL
Intervention: Caffeine 32 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 64 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 128 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 256 mg
Number of subjects: 20
Study: 30717746

Group type: EXPERIMENTAL
Intervention: Behavioral family‐based obesity intervention (LAUNCH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Motivational interviewing (MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (STC)
Number of subjects: 0
Study: 28298766

Group type: EXPERIMENTAL
Intervention: Higher thoracic epidural analgesia (HTEA) with fentanyl and bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous fentanyl analgesia
Number of subjects: 60
Study: 26431336

Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrient (MM) supplementation
Number of subjects: 396

Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) supplementation
Number of subjects: 396
Study: 23625090

Group type: EXPERIMENTAL
Intervention: Biatrial (BiA) pacing
Number of subjects: 28

Group type: COMPARATOR
Intervention: Right atrial appendage (RAA) pacing
Number of subjects: 28
Study: 21543429

Group type: EXPERIMENTAL
Intervention: EST expression in subcutaneous adipose tissue
Number of subjects: 16
Study: 20415678

Group type: EXPERIMENTAL
Intervention: Microsphere adapalene gel, applied once daily in the evening for 12 weeks
Number of subjects: 175

Group type: COMPARATOR
Intervention: Conventional adapalene gel, applied once daily in the evening for 12 weeks
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Microsphere adapalene gel
Number of subjects: 175

Group type: COMPARATOR
Intervention: Conventional adapalene gel
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 175
Study: 17760545

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) rinse
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 210
Study: 15155217

Group type: EXPERIMENTAL
Intervention: Single-dose voriconazole (3 mg/kg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Single-dose voriconazole (4 mg/kg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Multiple-dose voriconazole (6 mg/kg every 12 h on day 1, followed by 3 mg/kg every 12 h on day 2 to day 4 and 4 mg/kg every 12 h on day 4 to day 8)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Voriconazole (any dosage)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Voriconazole (4 mg/kg)
Number of subjects: 39
Study: 12219055

Group type: EXPERIMENTAL
Intervention: High-impact training (jumping)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no high-impact training)
Number of subjects: 74
Study: 9602227

Group type: EXPERIMENTAL
Intervention: Long-stretch compression bandage
Number of subjects: 43

Group type: COMPARATOR
Intervention: Short-stretch compression bandage
Number of subjects: 43
Study: 7981559

Group type: EXPERIMENTAL
Intervention: maize-cowpea-palm oil diet (group MCP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: commercially produced lactose-free, soy protein isolate formula (group SF)
Number of subjects: 69
Study: 2595636

Group type: EXPERIMENTAL
Intervention: 5 mg nebulised salbutamol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Matched saline placebo
Number of subjects: 16
Study: 1146748

Group type: EXPERIMENTAL
Intervention: 34 g protein intake
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 57 g protein intake
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 88 g protein intake
Number of subjects: 15
Study: 30782454

Group type: EXPERIMENTAL
Intervention: BS-SC group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BS-U200
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ES-U200
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ES-SC
Number of subjects: 96
Study: 28637740

Group type: EXPERIMENTAL
Intervention: Apple iPads
Number of subjects: 40

Group type: COMPARATOR
Intervention: Local standard low-vision aid care
Number of subjects: 40
Study: 24902684

Group type: EXPERIMENTAL
Intervention: DD monitor (group B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Regular monitor (group C)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: DD monitor (group D)
Number of subjects: 200
Study: 24138011

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316